In response to a glucose stimulus, insulin synthesis occurs in the pancreas through beta cells. In the case of type 1 diabetes, which is an autoimmune disorder, the insulin generating cells gets destroyed (Camaya, Donnelly & O’Brien, 2022). Type 1 diabetes is also known as juvenile-onset diabetes mellitus. In their teenage years, young individuals get affected by type 1 diabetes. Insulin is a hormone, and hence when the beta cells get destroyed, insulin deficiency occurs, and hence patients have to depend on exogenous sources throughout their life. Autoimmune b-cell destruction is caused by environmental or infective stimulus in genetically predisposed people. The onset of the disease occurs at a rapid pace, but the development of the disease is a slower process, and it leads to progressive immunological damage.
Various pills are available to treat diabetes (Ramli, Reddy & Oliver, 2019). Still, such pills are not beneficial for those affected with type 1 diabetes, as pills only work when insulin is produced from the pancreas. The drugs help in lowering the glucose levels in the blood. Insulin cannot be consumed orally as the acids and digestive juices present in the stomach break it down before entering the blood. The diabetic pills help produce more insulin, or the pills improve the efficacy of the insulin that already has been produced. Still, the pills cannot be insulin substitutes naturally synthesized by the body (Perkins, Sherr, & Mathieu, 2021). In type 2 diabetes certain amount of insulin is synthesized by the body, and the medications work as long as insulin is produced. Pathophysiology Of Type 1 Diabetes Example Paper
Codes of conduct, standards of practice and code of ethics are the NMBA nurses’ professional standards. Nurses must meet NMBA (Nursing and Midwifery Board of Australia) qualifications if they work in Australia (NMBA, 2022). According to the code of ethics, a nurse’s primary professional duty is to individuals who require medical aid and treatment. Nurses facilitate collaborative cooperation and choices between healthcare providers and the patient’s family by creating evidence-based, person-centered and safe practices, according to Principle 2 of the code of conduct. Informed consent is mentioned in Standard 2.3. It is a patient’s free choice whether or not to undergo therapy, recognizing the potential benefits and risks (NMBA, 2022). Nurses must recognize the right to informed consent by disclosing information about the patient’s care, providing the perfect opportunity for the client to pose questions, and behave following the consumer’s willingness for preference and consent, as when caring for children with varying levels of understanding. Before delivering treatment, it is critical to get informed consent. As a result, nurses must learn and obey the NMBA standards before delivering any medication (NMBA, 2022)
For controlling blood sugar levels in type 1 diabetes patients, medical practitioners suggest injecting insulin hormone under the skin or being taken subcutaneously to decrease blood sugar significantly. Insulin is normally produced in the human body, but it is altered in patients with type 1 diabetes. Several forms of insulin are available in the market, each with a different absorption and action rate. A different form of insulin protects for a certain amount of time because of its half-life. One of the available insulins is Insulin Aspart (NOVORAPID), fast-acting insulin (Senior & Hramiak, 2019). This hormone must be introduced with another medium or long-acting insulin hormone as it takes approximately 20 minutes to begin acting in the body when injected. The Peak effect of the hormone lasts for about 2 hours to 3hours, and it has been observed that the hormone stops working after approximately 5hours. Optisulin is a prime example of a long-acting insulin hormone because it protects for about 24 hours.
Taking several daily injections is a part of the basal-bolus injection technique (Cescon et al., 2020). A therapy called basal-bolus therapy encompasses an infusion after taking each meal which could simulate a situation in which how a non-diabetic body produces its insulin hormone. Long-acting insulin is required to regulate blood glucose levels in fasting, and a few short-acting insulin doses to regulate Blood sugar level surges during eating. This basal-bolus technique could help individuals with diabetes to regulate, measure and control their condition. Basal insulin, sometimes known as background insulin, is the key to maintaining steady blood sugar levels in the case of fasting. Bolus insulin hormone regulates BGL before or after a meal (Park & Yoon, 2021).
NovoRapid is an insulin supplement that swiftly absorbs and accurately replicates the body’s insulin hormone. Glucose from the bloodstream penetrates cells because of the insulin hormone substitute in the same way that naturally synthesized insulin does. It will permit it to start functioning much more quickly than the original human insulin. Optisulin comprises insulin glargine, which is analogous to human insulin with a prolonged duration of action (Godman et al., 2021). Insulin suppresses lipolysis, modulates proteolysis, and stimulates protein synthesis in adipose tissues. It decreases blood glucose levels by enhancing peripheral glucose absorption, especially in muscular tissues and skeletal fat, reducing hepatic glucose synthesis.
References
Awuchi, C. G., Echeta, C. K., & Igwe, V. S. (2020). Diabetes and the nutrition and diets for its prevention and treatment: a systematic review and dietetic perspective. Health Sciences Research, 6(1), 5-19. https://www.academia.edu/download/61997637/908084520200205-42671-lab2o8.pdf
Bahendeka, S., Kaushik, R., Swai, A. B., Otieno, F., Bajaj, S., Kalra, S., … & Karigire, C. (2019). EADSG guidelines: insulin storage and optimisation of injection technique in diabetes management. Diabetes Therapy, 10(2), 341-366. https://link.springer.com/article/10.1007/s13300-019-0574-x
Camaya, I., Donnelly, S., & O’Brien, B. (2022). Targeting the PI3K/Akt signaling pathway in pancreatic β?cells to enhance their survival and function: An emerging therapeutic strategy for type 1 diabetes. Journal of Diabetes. https://doi.org/10.1111/1753-0407.13252
Cescon, M., Deshpande, S., Nimri, R., Doyle III, F. J., & Dassau, E. (2020). Using iterative learning for insulin dosage optimization in multiple-daily-injections therapy for people with type 1 diabetes. IEEE Transactions on Biomedical Engineering, 68(2), 482-491. https://doi.org/10.1109/TBME.2020.3005622
Cherubini, V., Skrami, E., Iannilli, A., Cesaretti, A., Paparusso, A. M., Alessandrelli, M. C., … & Gesuita, R. (2018). Disordered eating behaviors in adolescents with type 1 diabetes: A cross?sectional population?based study in Italy. International Journal of Eating Disorders, 51(8), 890-898. https://doi.org/10.1002/eat.22889
Department of Health. (2022). Department of Health | Quality Use of Medicines (QUM). Www1.health.gov.au. Retrieved 21 April 2022, from https://www1.health.gov.au/internet/main/publishing.nsf/Content/nmp-quality.htm.
Easa, N., Alany, R. G., Carew, M., & Vangala, A. (2019). A review of non-invasive insulin delivery systems for diabetes therapy in clinical trials over the past decade. Drug Discovery Today, 24(2), 440-451. https://doi.org/10.1016/j.drudis.2018.11.010
Godman, B., Leong, T., Abubakar, A. R., Kurdi, A., Kalemeera, F., Rwegerera, G. M., … & Ogunleye, O. (2021). Availability and use of long-acting insulin analogues including their biosimilars across Africa; findings and implications. Internal Medicine, 11(4). https://strathprints.strath.ac.uk/77656/
Imam, S. Z. (2018). Proactive Initiatives of Dental Practitioners to Manage Emergency in the Dental Office. EC Dental Science, 17, 1086-1097. https://www.researchgate.net/profile/Syeda-Imam-3/publication/339747537_Proactive_Initiatives_of_Dental_Practitioners_to_Manage_Emergency_in_the_Dental_Office/links/5e62754f92851c7ce049cc36/Proactive-Initiatives-of-Dental-Practitioners-to-Manage-Emergency-in-the-Dental-Office.pdf
Liu, Y., Zeng, S., Ji, W., Yao, H., Lin, L., Cui, H., … & Pan, G. (2022). Emerging theranostic nanomaterials in diabetes and its complications. Advanced Science, 9(3), 2102466. https://doi.org/10.1002/advs.202102466
Mathew, P., Thoppil, D., & McClinton, T. (2021). Hypoglycemia (Nursing). https://europepmc.org/article/nbk/nbk568695
NMBA. (2022). Nursing and Midwifery Board of Australia – Professional standards. Nursingmidwiferyboard.gov.au. Retrieved 20 April 2022, from https://www.nursingmidwiferyboard.gov.au/codes-guidelines-statements/professional-standards.aspx.
Park, J. Y., & Yoon, K. H. (2021). Insulin Therapy. In Stroke Revisited: Diabetes in Stroke (pp. 117-129). Springer, Singapore. Pathophysiology Of Type 1 Diabetes Example Paper